LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 145 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $824,000 | -95.5% | 67,055 | -93.9% | 0.05% | -95.7% |
| Q2 2017 | $18,187,000 | -25.0% | 1,105,610 | -34.6% | 1.24% | -6.6% |
| Q1 2017 | $24,239,000 | +15.5% | 1,690,273 | +11.4% | 1.33% | +31.1% |
| Q4 2016 | $20,988,000 | +43.4% | 1,517,575 | +87.4% | 1.02% | +51.3% |
| Q3 2016 | $14,631,000 | +106.2% | 809,666 | +63.8% | 0.67% | +72.1% |
| Q2 2016 | $7,094,000 | +13.2% | 494,380 | -5.7% | 0.39% | +13.4% |
| Q1 2016 | $6,266,000 | -39.2% | 524,380 | -32.3% | 0.34% | -31.3% |
| Q4 2015 | $10,307,000 | +3.7% | 774,380 | -16.3% | 0.50% | +4.6% |
| Q3 2015 | $9,935,000 | – | 925,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |